tiprankstipranks
Barclays Keeps Their Buy Rating on Leidos Holdings (LDOS)
Blurbs

Barclays Keeps Their Buy Rating on Leidos Holdings (LDOS)

In a report released today, David E. Strauss from Barclays maintained a Buy rating on Leidos Holdings (LDOSResearch Report), with a price target of $145.00. The company’s shares closed last Friday at $123.83.

According to TipRanks, E. Strauss is a 3-star analyst with an average return of 2.2% and a 57.26% success rate. E. Strauss covers the Industrials sector, focusing on stocks such as Boeing, Spirit AeroSystems, and Raytheon Technologies.

Currently, the analyst consensus on Leidos Holdings is a Strong Buy with an average price target of $134.09, which is an 8.29% upside from current levels. In a report released on February 14, Truist Financial also maintained a Buy rating on the stock with a $135.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of $124.93 and a one-year low of $75.70. Currently, Leidos Holdings has an average volume of 743.7K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Leidos Holdings (LDOS) Company Description:

Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company’s customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Read More on LDOS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles